The administration of fibrinogen concentrate (a component of blood involved in clotting process) to be given to those women who, after delivery of babies, develop severe bleeding to establish if this drug will prevent further blood loss or reduce the volume of blood loss.
The effect of Upfront Administration of Fibrinogen concentrate on total blood volume loss in Obstetric Haemorrhage – A Pilot study
Auckland City Hospital
245 participants
Dec 1, 2014
Interventional
Conditions
Summary
Severe bleeding after delivery is a worldwide cause of mothers dying during childbirth. We can identify some of those woman at risk but in most cases there is no indication that a woman may bleed. We suspect in those cases the severe bleeding that develop is due to a low level of a clotting factor called Fibrinogen in their blood. Studies have demonstrated that there is a link between low level of fibrinogen (that helps blood clot) and those woman that have severe bleeding after delivery. We hope that to correct the level of fibrinogen will prevent severe bleeding.
Eligibility
Inclusion Criteria3
- Insure both criteria 1) and 2) are satisfied;
- Women with estimated blood loss greater than 1000mL in the immediate postpartum period (<4 hours postpartum).
- Women with persistent PPH not responding to first line uterotonic therapy (i.e. syntocinon infusion), and manual uterine compression in whom further haemostatic intervention is being considered.
Exclusion Criteria4
- Women with coagulopathic disorder secondary to pre-existing liver disease.
- Women with confirmed venous thromboembolism occurring in the last 4 weeks of pregnancy
- Women with confirmed allergy to fibrinogen concentrate
- Woman who refuse blood products
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A single dose of Fibrinogen concentrate 4g given intra-venously upfront in women after delivery with a post partum blood loss of more than 1000mls and with signs of ongoing bleeding.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12614000691640